1
Functional Changes in the Diaphragm of HF Rats Changes in EDL muscle in HF rats Model Development Rotarod Running in HF Rats Changes in Diaphragm Muscle in HF Rats Heart failure (HF) is associated with skeletal muscle dysfunction and exercise intolerance. Small molecule, fast skeletal troponin activators increase sarcomere calcium sensitivity and muscle force at sub-maximal nerve stimulation rates while reducing muscle fatigability in both an in situ model of vascular insufficiency and rotarod running. Here we show the fast skeletal troponin activator, CK-2127107, improves exercise capacity in a rat model of heart failure produced by ligation of the left anterior descending artery. Exercise performance was assessed in HF rats at 11-12 weeks post-surgery using a fatiguing rotarod protocol (5 min forced-run ramped from 14-16 RPM followed by run time assessment during a 10 min ramp from 12 to 25 RPM). HF rats were selected based on a left ventricular fractional shortening <25% and reduced run time compared to sham controls. Rats received CK-2127107 (10 mg/kg P.O.) or vehicle in a randomized, blinded, 2-way cross-over study design. Vehicle-treated sham rats ran longer than vehicle- treated HF rats (198 ± 26 vs. 111 ± 32 sec, p=0.042, mean ± S.E.). CK-2127107 treated sham rats ran longer than vehicle treated sham rats (275 ± 31 vs. 198 ± 26 sec, p=0.022, mean ± S.E.). HF rats treated with CK-2127107 increased their rotarod running time approximately 2.5-fold compared to vehicle treatment to 277 ± 32 sec (p=0.0004 by ANCOVA), completely normalizing exercise capacity in HF rats. Hind limb muscles showed no major differences in contractility, fatigability or fiber type composition between groups. The diaphragm was characterized by muscle atrophy and fiber type switching toward slow fibers. Diaphragm tissue exhibited decreased contractility and reduced calcium sensitivity, which was corrected by CK-2127107. Overall, CK-2127107 increased fatigue resistance in HF rats. These studies suggest that fast skeletal troponin activators, by increasing calcium sensitivity of the fast skeletal muscle sarcomere, may be useful to improve exercise tolerance in patients with HF. Rotarod running in normal rats CK-2127107 produced a dose-dependent increase in running time in healthy rats. Following a dose of 10mg/kg an increase of up to 2.5 fold was observed. Rotarod running in heart failure rats Heart failure resulted in reduced rotarod running time compared to sham operated controls (198 ± 26 vs. 111 ± 32 sec, p=0.042, mean ± S.E.). CK-2127107 treated sham rats ran longer than vehicle treated sham rats (275 ± 31 vs. 198 ± 26 sec, p=0.022, mean ± S.E.). HF rats treated with CK-2127107 increased their rotarod running time approximately 2.5-fold compared to vehicle treatment to 277 ± 32 sec (p=0.0004 by ANCOVA), completely normalizing exercise capacity in HF rats. Fiber type distribution and skinned fiber analysis of EDL Mean EDL cross sectional area and fiber type distribution were not significantly different between SHAM and LAD animals. There was no difference in the force-pCA relationship between SHAM and LAD EDL fibers. CK-2127107 (3μM) caused a significant leftward shift in the force-Ca 2+ relationship in both SHAM and LAD EDL muscle. Diaphragm contractility Mean diaphragm cross sectional area was significantly lower in LAD diaphragm muscle. Within individual fiber types, significant atrophy in type IIa and type IIb/x fibers was observed in LAD diaphragms. Fiber type distribution characterized by myosin ATPase activity was not significantly different between SHAM and LAD animals. Compared to SHAM diaphragms, HF diaphragm fibers had significantly lower Ca 2+ sensitivity. CK-2127107 (30 μM) significantly increased Ca 2+ sensitivity in both SHAM and HF diaphragm fibers. The force-frequency relationship of SHAM and LAD diaphragms were measured ex vivo by electrical field stimulation. LAD diaphragm muscle produced significantly lower force compared to Sham diaphragm muscle. CK-2127107 (30 μM) significantly increased force in both SHAM and LAD diaphragms at submaximal frequencies of electrical stimulation. Overall, CK-2127107 improved the impaired force production in LAD diaphragms. Figure 1: a) Fractional shortening LAD animals is decreased over time, when compared to baseline or sham controls. b) Example of rotarod protocol. c) Dose dependent improvement in running time for young female rats in the fatiguing rotarod assay. Figure 3: Fiber type distribution in the EDL. a) Heart failure is not associated with changes in fiber type distribution or cross sectional area. b) Skinned fibers from EDL muscles respond to CK-2127107 by a leftward shift in the pCa curve. No difference is seen between LAD and Sham treated animals. ABSTRACT Heart failure affects over 5 million people in the United States alone (Roger et al., 2012). In addition to the increased risk of mortality, heart failure patients exhibit muscle weakness, fatigue, and exercise intolerance, which reduces the quality of life. While such fatigue is common in heart failure patients, there appears to be little correlation between fatigue and the severity of the disease itself, suggesting that the fatigue is due to changes that go beyond poor perfusion due reduced cardiac function (Lunde et al., 2001). Heart failure is associated with morphological changes in skeletal muscle that include atrophy and changes in fiber type distribution, toward a greater prevalence of fast twitch muscles. These changes lead to decreases in maximum voluntary contractile force and increased fatigability in patients (Sullivan and Hawthorne 1995). Exercise intolerance and fatigue has been shown to be amenable to modification in both animals and humans (Chung et al., 2011, Bosnak-Guclu et al., 2011). In particular training of respiratory muscles has been shown to be effective in reducing exercise intolerance (Bosnak-Guclu et al., 2011). Whilst exercise has been shown to have no major impact on long term survival in these patients (O’Connor et al., 2009), improvement of fatigue symptoms may improve quality of life. Small molecule, fast skeletal troponin activators increase sarcomere calcium sensitivity and muscle force at sub-maximal nerve stimulation rates (Russell et al., 2012). I a model of vascular insufficiency, they reduced the fatigability of the extensor digitorum longus (EDL) muscle in situ, increasing the overall tension achieved over the course of the fatigue protocol. Tirasemtiv increased running time on both rotarod and treadmill (Kennedy et al., 2012). CK-2127107 is a novel small molecule activator of the fast skeletal muscle troponin complex that acts in a similar way to those previously published (Russell et al., 2012; Kennedy et al., 2012). As such we have undertaken studies to describe the effects of CK-2127107 on the exercise intolerance induced in a rat model of heart failure. INTRODUCTION Animals Female Sprague Dawley rats (175-200g) were obtained from Charles River Laboratories with ligation of the left anterior descending coronary artery performed prior to shipment. Sham operated animals were also obtained from the same source. Echocardiographic assessment of fractional shortening was performed upon arrival and at 2, 4, 7 and 10 weeks after arrival (Figure 1a). Only animals that showed a fractional shortening of less than 25% were used as study animals. Animals that did not show such reductions were excluded from the study. Post-mortem analysis of heart weight and infarct size was performed on animals used in the study (figure 2). Measurement of exercise capacity Rats were assessed according to a protocol developed at Cytokinetics to assess motor coordination under fatiguing conditions (Figure 1b), and that had previously shown CK-2127107 to be effective at increasing running time in young healthy rats (Figure 1c). On the day of the experiment animals were dosed thirty minutes prior to start of test. The test began with a 5-minute primer session, whereby animals were run at an increasing speed from 14-16 RPM over 5 minutes. Rats were then run at a constantly accelerating rate from 12 RPM to 25 RPM over the course of 10 minutes. Once 25 RPM had been reached, a constant speed of 25 RPM was maintained for an additional 5 minutes. Time to fall was recorded, with the test being terminated at 900 seconds. The following day animals were assessed again in a cross over design, where each animal was assessed with and without treatment. Assessment of myocardial infarct Hearts from animals used on study were dissected free, flushed of blood, blotted dry and weighed (Figure 2a). Hearts were fixed and paraffin embedded, sectioned and stained with Masson’s trichrome (Figure 2b). Fiber type analysis Serial frozen cross sections were cut at 10 μm and stained for myosin ATPase after preincubation at pH 4.35. Stained fibers were classified Type I, Type IIa, or Type II b/x and measured for individual myofiber cross-sectional area (μm2). Muscle tissue experiments Muscle tissue for in vitro skinned fiber studies were prepared using an adapted protocol based on Lynch and Faulkner (1998). Single skinned fibers were then suspended between a 400A force transducer (Aurora Scientific, Ontario, Canada) and a fixed post. Tension was generated in each fiber by changing fiber buffer over to relax buffer (20 µM MOPS, 5.5 µM MgCl 2 , 132 µM potassium acetate, 4.4 µM ATP, 22 µM creatine phosphate, 1 mg/ml creatine kinase, 1 mM DTT, 44 ppm antifoam , pH 7) supplemented with 1 mM EGTA and a 15 mM solution of calcium chloride in varying proportions. CK- 2127107 was added to these buffers from a DMSO solution (final DMSO concentration =1%). Diaphragm Force-Frequency relationship Diaphragm contractile force was measured by electrical field stimulation in an organ bath system (Radnoti) based on a standard operating protocol adapted from the Treat NMD website. (http://www.treat-nmd.eu/downloads/file/sops/dmd/MDX/DMD_M.1.2.00 2.pdf). Diaphragm strips were set to a length that produced maximum twitch tension (Lo). The force-frequency profile of the muscle was obtained by stimulating the muscle at frequencies between 10-150 Hz (Grass Stimulator, 800 ms train duration, 0.6 ms pulse width). CK-2127107 was dissolved in DMSO and directly added into the bath. METHODS RESULTS In rats with heart failure and decreased exercise tolerance compared to sham operated controls, CK-2127107 increased exercise performance. Diaphragm and certain limb muscles atrophy in this model of heart failure; CK-2127107 increases their calcium sensitivity and increases overall, sub- maximal force development. The diaphragm from heart failure animals showed significant myofiber atrophy, particularly in the fast skeletal fibers. Consistent with this, diaphragm strips displayed a reduced peak tension, a deficit that was partly corrected by CK-2127107. In this model of heart failure, CK-2127107 improves exercise tolerance. The mechanism of this improvement may include improved respiratory muscle function and reduced fatigability of limb muscles. CK-2127107 IMPROVES MUSCLE FUNCTION AND EXERCISE CAPACITY IN A RAT HEART FAILURE MODEL Adam R Kennedy, Darren Hwee, Julie Ryans, Nathan Heald, Alisha Ardiana, Arash Pakdel, Fady I Malik, Jeffrey R Jasper Cytokinetics Inc, South San Francisco, CA SUMMARY AND CONCLUSIONS Bosnak-Guclu M et al. Respir Med. 2011 Nov;105(11): 1671-81. Brooke MH, Kaiser KK. Arch Neurol. 1970;23(4):369-379 Chung CJ, Schulze PC. Phys Sportsmed. 2011 Nov;39(4):37-43. Kennedy AR et al. 2012 Experimental Biology Annual Conference in San Diego, CA, April 2012. Lunde PK et al. Acta Physiol Scand. 2001 Mar;171(3): 277-94. Lynch GS, Faulkner JA. Am J Physiol. 1998 Dec;275 (6 Pt 1):C1548-54. O'Connor CM et al. JAMA. 2009 Apr 8;301(14):1439-50. Roger VL et al. Circulation. 2012;125(1):e2–220. Russell AJ et al. Nature Medicine, 2011;378:667-75. Sullivan MJ, Hawthorne MH. Prog Cardiovasc Dis. 1995 Jul-Aug;38(1):1-22. REFERENCES Figure 4: Heart Failure induces significant atrophy in the Diaphragm of LAD animals. a) Photomicrographs of ATPase stained diaphragm from LAD and sham animals. b) Changes in fiber-type distribution and cross-sectional area in diaphragm from LAD animals compared to Sham. Figure 5: Heart failure leads to atrophy of the diaphragm. a) CK-2127107 increases sub maximal tension in diaphragm strips from both LAD and sham animals. (Data is expressed as a % of maximum sham force). b) Comparison of vehicle and CK-2127107 effects on Diaphragm strips from LAD animals to untreated strips from sham animals, showing a partial return to sham levels. c) Skinned fibers from diaphragms obtained from sham and LAD animals, showing a slight rightward shift in calcium response in LAD animals and a leftward shift in calcium response in fibers from diaphragms of both LAD and sham animals. Figure 2: CK-2127107 (10mg/kg, PO) increases rotarod running time in rats with heart failure-induced exercise intolerance and control rats. Running time was significantly decreased in heart failure animals, with CK-2127107 increasing run time in both heart failure and sham animals to a level, not significantly different from one another. 0 2 4 6 8 10 0 20 40 60 LAD Sham Week %Fractional Shortening 30 Primer Test 20 10 0 0 5 10 15 Log [Ca 2+ ] (M) Skinned EDL Force - Ca 2+ relationship 10 -8 10 -7 10 -6 10 -5 10 -4 0 20 40 60 80 100 120 140 LAD (n=6) SHAM (n=7) LAD + 3μM CK-2127107 (n=6) SHAM + 3μM CK-2127107 (n=7) %ofBasalMaximal Tension vehicle 1 3 10 30 0 200 400 600 800 * *** *** *** *=P<0.05, ***=P<0.001 by 1 way ANOVA and Post Hoc Dunnetts test Dose CK-2127107 (mg/kg) Time on Rotorod (sec) 0 20 40 60 80 100 120 Sham (n=10) Sham + 30 μM CK-2127107 (n=9) LAD (n=10) LAD + 30 μM CK-2127107 (n=10) 5 10 20 30 40 50 60 80 Frequency of Stimulation (Hz) % of Maximum Sham Force 5 10 20 30 40 50 60 80 0 20 40 60 80 100 120 Sham (n=10) LAD (n=10) LAD + 30 μM CK-2127107 (n=10) Frequency of Stimulation (Hz) % of Maximum Sham Force Skinned Diaphragm Force - Ca 2+ relationship 10 -8 10 -7 10 -6 10 -5 10 -4 0 20 40 60 80 100 120 LAD (n=7) LAD + 3μM CK-2127107 (n=6) SHAM + 3μM CK-2127107 (n=8) SHAM (n=7) Log [Ca 2+ ] (M) % of Basal Maximal Tension Sham HF 0 100 200 300 400 Vehicle (n=20) CK-2127107 (n=13) p=0.0004 p=0.022 p=0.042 Time on Rotarod (sec)

Cytokinetics Inc, South San Francisco, CA...Functional Changes in the Diaphragm of HF Rats Changes in EDL muscle in HF rats Model Development Rotarod Running in HF Rats Changes in

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Cytokinetics Inc, South San Francisco, CA...Functional Changes in the Diaphragm of HF Rats Changes in EDL muscle in HF rats Model Development Rotarod Running in HF Rats Changes in

Functional Changes in the Diaphragm of HF Rats

Changes in EDL muscle in HF rats

Model Development

Rotarod Running in HF Rats

Changes in Diaphragm Muscle in HF Rats

Heart failure (HF) is associated with skeletal muscle dysfunction and exercise intolerance. Small molecule, fast skeletal troponinactivators increase sarcomere calcium sensitivity and muscle force at sub-maximal nerve stimulation rates while reducing musclefatigability in both an in situ model of vascular insufficiency and rotarod running. Here we show the fast skeletal troponin activator,CK-2127107, improves exercise capacity in a rat model of heart failure produced by ligation of the left anterior descending artery.

Exercise performance was assessed in HF rats at 11-12 weeks post-surgery using a fatiguing rotarod protocol (5 min forced-runramped from 14-16 RPM followed by run time assessment during a 10 min ramp from 12 to 25 RPM). HF rats were selected basedon a left ventricular fractional shortening <25% and reduced run time compared to sham controls. Rats received CK-2127107 (10 mg/kg P.O.) or vehicle in a randomized, blinded, 2-way cross-over study design. Vehicle-treated sham rats ran longer than vehicle-treated HF rats (198 ± 26 vs. 111 ± 32 sec, p=0.042, mean ± S.E.). CK-2127107 treated sham rats ran longer than vehicle treated shamrats (275 ± 31 vs. 198 ± 26 sec, p=0.022, mean ± S.E.). HF rats treated with CK-2127107 increased their rotarod running timeapproximately 2.5-fold compared to vehicle treatment to 277 ± 32 sec (p=0.0004 by ANCOVA), completely normalizing exercisecapacity in HF rats. Hind limb muscles showed no major differences in contractility, fatigability or fiber type composition betweengroups. The diaphragm was characterized by muscle atrophy and fiber type switching toward slow fibers. Diaphragm tissueexhibited decreased contractility and reduced calcium sensitivity, which was corrected by CK-2127107.

Overall, CK-2127107 increased fatigue resistance in HF rats. These studies suggest that fast skeletal troponin activators, by increasingcalcium sensitivity of the fast skeletal muscle sarcomere, may be useful to improve exercise tolerance in patients with HF.

Rotarod running in normal rats

CK-2127107 produced a dose-dependent increase in running time in healthy rats. Following a dose of 10mg/kg an increase of up to2.5 fold was observed.

Rotarod running in heart failure rats

Heart failure resulted in reduced rotarod running time compared to sham operated controls (198 ± 26 vs. 111 ± 32 sec, p=0.042,mean ± S.E.). CK-2127107 treated sham rats ran longer than vehicle treated sham rats (275 ± 31 vs. 198 ± 26 sec, p=0.022, mean ± S.E.). HF rats treated with CK-2127107 increased their rotarod running time approximately 2.5-fold compared to vehicletreatment to 277 ± 32 sec (p=0.0004 by ANCOVA), completely normalizing exercise capacity in HF rats.

Fiber type distribution and skinned fiber analysis of EDL

Mean EDL cross sectional area and fiber type distribution were not significantly different between SHAM and LAD animals. Therewas no difference in the force-pCA relationship between SHAM and LAD EDL fibers. CK-2127107 (3µM) caused a significant leftwardshift in the force-Ca2+ relationship in both SHAM and LAD EDL muscle.

Diaphragm contractility

Mean diaphragm cross sectional area was significantly lower in LAD diaphragm muscle. Within individual fiber types, significantatrophy in type IIa and type IIb/x fibers was observed in LAD diaphragms. Fiber type distribution characterized by myosin ATPaseactivity was not significantly different between SHAM and LAD animals.

Compared to SHAM diaphragms, HF diaphragm fibers had significantly lower Ca2+ sensitivity. CK-2127107 (30 µM) significantlyincreased Ca2+ sensitivity in both SHAM and HF diaphragm fibers.

The force-frequency relationship of SHAM and LAD diaphragms were measured ex vivo by electrical field stimulation.

LAD diaphragm muscle produced significantly lower force compared to Sham diaphragm muscle. CK-2127107 (30 µM) significantlyincreased force in both SHAM and LAD diaphragms at submaximal frequencies of electrical stimulation.

Overall, CK-2127107 improved the impaired force production in LAD diaphragms.

Figure 1: a) Fractional shortening LAD animals is decreased over time, when compared to baseline or sham controls. b) Exampleof rotarod protocol. c) Dose dependent improvement in running time for young female rats in the fatiguing rotarod assay.

Figure 3: Fiber type distribution in the EDL. a) Heart failure is not associated with changes in fiber type distribution or crosssectional area. b) Skinned fibers from EDL muscles respond to CK-2127107 by a leftward shift in the pCa curve. No difference isseen between LAD and Sham treated animals.

ABSTRACT

Heart failure affects over 5 million people in the United States alone (Roger et al., 2012). In addition to the increased risk ofmortality, heart failure patients exhibit muscle weakness, fatigue, and exercise intolerance, which reduces the quality of life.While such fatigue is common in heart failure patients, there appears to be little correlation between fatigue and the severityof the disease itself, suggesting that the fatigue is due to changes that go beyond poor perfusion due reduced cardiac function(Lunde et al., 2001).

Heart failure is associated with morphological changes in skeletal muscle that include atrophy and changes in fiber typedistribution, toward a greater prevalence of fast twitch muscles. These changes lead to decreases in maximum voluntarycontractile force and increased fatigability in patients (Sullivan and Hawthorne 1995).

Exercise intolerance and fatigue has been shown to be amenable to modification in both animals and humans (Chung et al.,2011, Bosnak-Guclu et al., 2011). In particular training of respiratory muscles has been shown to be effective in reducing exerciseintolerance (Bosnak-Guclu et al., 2011). Whilst exercise has been shown to have no major impact on long term survival in thesepatients (O’Connor et al., 2009), improvement of fatigue symptoms may improve quality of life.

Small molecule, fast skeletal troponin activators increase sarcomere calcium sensitivity and muscle force at sub-maximal nervestimulation rates (Russell et al., 2012). I a model of vascular insufficiency, they reduced the fatigability of the extensor digitorumlongus (EDL) muscle in situ, increasing the overall tension achieved over the course of the fatigue protocol. Tirasemtiv increasedrunning time on both rotarod and treadmill (Kennedy et al., 2012). CK-2127107 is a novel small molecule activator of the fastskeletal muscle troponin complex that acts in a similar way to those previously published (Russell et al., 2012; Kennedy et al.,2012). As such we have undertaken studies to describe the effects of CK-2127107 on the exercise intolerance induced in a ratmodel of heart failure.

INTRODUCTION

Animals

Female Sprague Dawley rats (175-200g) were obtained from Charles River Laboratories with ligation of the left anteriordescending coronary artery performed prior to shipment. Sham operated animals were also obtained from the samesource.

Echocardiographic assessment of fractional shortening was performed upon arrival and at 2, 4, 7 and 10 weeks afterarrival (Figure 1a). Only animals that showed a fractional shortening of less than 25% were used as study animals. Animalsthat did not show such reductions were excluded from the study.

Post-mortem analysis of heart weight and infarct size was performed on animals used in the study (figure 2).

Measurement of exercise capacity

Rats were assessed according to a protocol developed at Cytokinetics to assess motor coordination under fatiguingconditions (Figure 1b), and that had previously shown CK-2127107 to be effective at increasing running time in younghealthy rats (Figure 1c).

On the day of the experiment animals were dosed thirty minutes prior to start of test. The test began with a 5-minuteprimer session, whereby animals were run at an increasing speed from 14-16 RPM over 5 minutes. Rats were then run ata constantly accelerating rate from 12 RPM to 25 RPM over the course of 10 minutes. Once 25 RPM had been reached, aconstant speed of 25 RPM was maintained for an additional 5 minutes. Time to fall was recorded, with the test beingterminated at 900 seconds. The following day animals were assessed again in a cross over design, where each animal wasassessed with and without treatment.

Assessment of myocardial infarct

Hearts from animals used on study were dissected free, flushed of blood, blotted dry and weighed (Figure 2a). Heartswere fixed and paraffin embedded, sectioned and stained with Masson’s trichrome (Figure 2b).

Fiber type analysis

Serial frozen cross sections were cut at 10 µm and stained for myosin ATPase after preincubation at pH 4.35. Stained fiberswere classified Type I, Type IIa, or Type II b/x and measured for individual myofiber cross-sectional area (µm2).

Muscle tissue experiments

Muscle tissue for in vitro skinned fiber studies were prepared using an adapted protocol based on Lynch and Faulkner(1998). Single skinned fibers were then suspended between a 400A force transducer (Aurora Scientific, Ontario, Canada)and a fixed post. Tension was generated in each fiber by changing fiber buffer over to relax buffer (20 µM MOPS, 5.5 µMMgCl2, 132 µM potassium acetate, 4.4 µM ATP, 22 µM creatine phosphate, 1 mg/ml creatine kinase, 1 mM DTT, 44 ppmantifoam , pH 7) supplemented with 1 mM EGTA and a 15 mM solution of calcium chloride in varying proportions. CK-2127107 was added to these buffers from a DMSO solution (final DMSO concentration =1%).

Diaphragm Force-Frequency relationship

Diaphragm contractile force was measured by electrical field stimulation in an organ bath system (Radnoti) based on astandard operating protocol adapted from the Treat NMD website.

(http://www.treat-nmd.eu/downloads/file/sops/dmd/MDX/DMD_M.1.2.00 2.pdf). Diaphragm strips were set to a lengththat produced maximum twitch tension (Lo). The force-frequency profile of the muscle was obtained by stimulating themuscle at frequencies between 10-150 Hz (Grass Stimulator, 800 ms train duration, 0.6 ms pulse width). CK-2127107 wasdissolved in DMSO and directly added into the bath.

METHODS

RESULTS

In rats with heart failure and decreasedexercise tolerance compared to shamoperated contro ls, CK-2127107increased exercise performance.

Diaphragm and certain limb musclesatrophy in this model of heart failure;CK-2127107 increases their calciumsensitivity and increases overall, sub-maximal force development.

The diaphragm from heart failureanimals showed significant myofiberatrophy, particularly in the fast skeletalfibers. Consistent with this, diaphragmstrips displayed a reduced peaktension, a deficit that was partlycorrected by CK-2127107.

In this model of heart failure, CK-2127107 improves exerc i setolerance. The mechanism of thisimprovement may include improvedrespiratory muscle function andreduced fatigability of limb muscles.

CK-2127107 IMPROVES MUSCLE FUNCTION AND EXERCISE CAPACITY IN A RAT HEART FAILURE MODELAdam R Kennedy, Darren Hwee, Julie Ryans, Nathan Heald, Alisha Ardiana, Arash Pakdel, Fady I Malik, Jeffrey R Jasper

Cytokinetics Inc, South San Francisco, CA

SUMMARY AND CONCLUSIONS

Bosnak-Guclu M et al. Respir Med. 2011 Nov;105(11):1671-81.

Brooke MH, Kaiser KK. Arch Neurol. 1970;23(4):369-379

Chung CJ, Schulze PC. Phys Sportsmed. 2011Nov;39(4):37-43.

Kennedy AR et al. 2012 Experimental Biology AnnualConference in San Diego, CA, April 2012.

Lunde PK et al. Acta Physiol Scand. 2001 Mar;171(3):277-94.

Lynch GS, Faulkner JA. Am J Physiol. 1998 Dec;275(6 Pt 1):C1548-54.

O'Connor CM et al. JAMA. 2009 Apr 8;301(14):1439-50.

Roger VL et al. Circulation. 2012;125(1):e2–220.

Russell AJ et al. Nature Medicine, 2011;378:667-75.

Sullivan MJ, Hawthorne MH. Prog Cardiovasc Dis. 1995Jul-Aug;38(1):1-22.

REFERENCES

Figure 4: Heart Failure induces significant atrophy in the Diaphragm of LAD animals. a) Photomicrographs of ATPase staineddiaphragm from LAD and sham animals. b) Changes in fiber-type distribution and cross-sectional area in diaphragm from LADanimals compared to Sham.

Figure 5: Heart failure leads to atrophy of the diaphragm. a) CK-2127107 increases sub maximal tension in diaphragm strips fromboth LAD and sham animals. (Data is expressed as a % of maximum sham force). b) Comparison of vehicle and CK-2127107 effectson Diaphragm strips from LAD animals to untreated strips from sham animals, showing a partial return to sham levels. c) Skinnedfibers from diaphragms obtained from sham and LAD animals, showing a slight rightward shift in calcium response in LAD animalsand a leftward shift in calcium response in fibers from diaphragms of both LAD and sham animals.

Figure 2: CK-2127107 (10mg/kg, PO) increases rotarod running time in rats with heart failure-induced exercise intolerance andcontrol rats. Running time was significantly decreased in heart failure animals, with CK-2127107 increasing run time in bothheart failure and sham animals to a level, not significantly different from one another.

0 2 4 6 8 100

20

40

60

LADSham

Week

%F

racti

on

al S

ho

rten

ing

30Primer

Test

20

10

00 5 10 15

Log [Ca2+] (M)

Skinned EDL

Force - Ca2+ relationship

10 -8 10 -7 10 -6 10 -5 10 -4

0

20

40

60

80

100

120

140

LAD (n=6)

SHAM (n=7)

LAD + 3μM CK-2127107 (n=6)

SHAM + 3μM CK-2127107 (n=7)

%o

fB

asalM

axim

alT

en

sio

n

vehicl

e 1 3 10 300

200

400

600

800

*

*********

*=P<0.05, ***=P<0.001 by 1 way ANOVA and Post Hoc Dunnetts test

Dose CK-2127107 (mg/kg)

Tim

e on

Rot

orod

(sec

)

0

20

40

60

80

100

120Sham (n=10)Sham + 30 µM CK-2127107 (n=9)LAD (n=10)LAD + 30 µM CK-2127107 (n=10)

5 10 20 30 40 50 60 80

Frequency of Stimulation (Hz)

% o

f Max

imum

Sha

m F

orce

5 10 20 30 40 50 60 800

20

40

60

80

100

120 Sham (n=10)LAD (n=10)LAD + 30 µM CK-2127107 (n=10)

Frequency of Stimulation (Hz)

% o

f Max

imum

Sha

m F

orce

Skinned Diaphragm Force - Ca2+ relationship

10 -8 10 -7 10 -6 10 -5 10 -4

0

20

40

60

80

100

120

LAD (n=7)LAD + 3µM CK-2127107 (n=6)

SHAM + 3µM CK-2127107 (n=8)SHAM (n=7)

Log [Ca2+] (M)

%of

Bas

alM

axim

alTe

nsio

n

Sham HF0

100

200

300

400

Vehicle (n=20) CK-2127107 (n=13)

p=0.0004p=0.022

p=0.042

Tim

e on

Rot

arod

(sec

)